Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis

被引:5
|
作者
Behrens, Edward M.
Beukelman, Timothy
Paessler, Michele
Cron, Randy Q.
机构
[1] Childrens Hosp, Dept Pediat, Div Rheumatol, Philadelphia, PA 19104 USA
[2] Childrens Hosp, Dept Pathol, Philadelphia, PA 19104 USA
[3] Univ Penn, Sch Med, Philadelphia, PA 19104 USA
关键词
macrophage activation syndrome; systemic juvenile idiopathic arthritis; hemophagocytosis; CD163; antigen; bone marrow aspirate; hemophagocytic lymphohistiocytosis;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. Macrophage activation syndrome (MAS) is a well described, but purportedly uncommon manifestation of systemic juvenile idiopathic arthritis (SJIA). There is evidence to suggest that macrophage activation is integral to the pathogenesis of SJIA, Accordingly, many patients with SJIA may have evidence of mild MAS that is not appreciated clinically. We investigated the prevalence of occult MAS in children with SJIA by reviewing bone marrow aspirates (BMA). Methods. Patients diagnosed with SJIA who underwent bone marrow aspiration were identified retrospectively. Patients admitted with a diagnosis of fever of unknown origin and discharged with a diagnosis other than SJIA or malignancy, and who had a BMA, were identified as controls. The BMA were reviewed by a single hematopathologist for evidence of MAS, ranging from activated macrophages to frank hemophagocytic cells. Results. Eight of 15 (53%) patients with SJIA had BMA suggestive of MAS. Two of 15 patients (13%) were diagnosed clinically with MAS. Three patients (20%) were noted to have frank hemophagocytosis, only one of whom was diagnosed with MAS clinically. There were no statistically significant differences in the laboratory values for the patients with and without evidence of MAS on BMA. There was no evidence of increased macrophage activity or hemophagocytosis in any of the control BMA. Conclusion. Occult MAS appears to be common in patients with SJIA who undergo BMA. This suggests that macrophage activation may be integral to the pathogenesis of SJIA, with implications for treatment.
引用
收藏
页码:1133 / 1138
页数:6
相关论文
共 50 条
  • [31] Risk Score of Macrophage Activation Syndrome (MAS) in Patients with Systemic Juvenile Idiopathic Arthritis (sJIA)
    Carbogno, Simone
    Marafon, Denise Pires
    Marucci, Giulia
    Sacco, Emanuela
    Pardeo, Manuela
    Alsaleem, Alhanouf
    Fingerhutova, Sarka
    Demir, Ferhat
    Cekada, Nastasia
    Kostik, Mikhail
    Kessel, Christoph
    Vougiouka, Olga
    Gagro, Alenka
    Tibaldi, Jessica
    Minoia, Francesca
    Maccora, Ilaria
    Schneider, Rayfel
    Dolezalova, Pavla
    Sozeri, Betul
    Jelusic, Marija
    Insalaco, Antonella
    De Benedetti, Fabrizio
    Bracaglia, Claudia
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [32] Evaluation of Macrophage Activation Syndrome in Patients with Systemic Juvenile Idiopathic Arthritis: A Single Center Experience
    Hoeg, Pia Elkjaer
    Glerup, Mia
    Mahler, Birgitte
    Host, Christian
    Herlin, Troels
    INTERNATIONAL JOURNAL OF RHEUMATOLOGY, 2022, 2022
  • [33] Macrophage activation syndrome during treatment with biological therapy in patients with systemic juvenile idiopathic arthritis
    Alina Lucica Boteanu
    Maria Angeles Blazquez Cañamero
    Valentina Maldonado Romero
    Maria Luz Gámir Gámir
    Pediatric Rheumatology, 12 (Suppl 1)
  • [34] Dissecting the Heterogeneity of Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis
    Minoia, Francesca
    Davi, Sergio
    Horne, AnnaCarin
    Bovis, Francesca
    Demirkaya, Erkan
    Akikusa, Jonathan
    Ayaz, Nuray A.
    Al-Mayouf, Sulaiman M.
    Barone, Patrizia
    Bica, Bianca
    Bolt, Isabel
    Breda, Luciana
    De Cunto, Carmen
    Enciso, Sandra
    Gallizzi, Romina
    Griffin, Thomas
    Hennon, Teresa
    Horneff, Gerd
    Jeng, Michael
    Kapovic, Ageza M.
    Lipton, Jeffrey M.
    Manzoni, Silvia Magni
    Rumba-Rozenfelde, Ingrida
    Magalhaes, Claudia Saad
    Sewairi, Wafaa M.
    Stine, Kimo C.
    Vougiouka, Olga
    Weaver, Lehn K.
    Davidsone, Zane
    De Inocencio, Jaime
    Ioseliani, Maka
    Lattanzi, Bianca
    Tezer, Hasan
    Buoncompagni, Antonella
    Picco, Paolo
    Ruperto, Nicolino
    Martini, Alberto
    Cron, Randy Q.
    Ravelli, Angelo
    JOURNAL OF RHEUMATOLOGY, 2015, 42 (06) : 994 - 1001
  • [35] BONE MARROW TRANSPLANT FOR MACROPHAGE ACTIVATION SYNDROME IN SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS
    Gaur, Shailly
    Holland, Michael
    Ahmed, Ibrahim
    Hays, J. Allyson
    PEDIATRIC BLOOD & CANCER, 2023, 70 : S194 - S195
  • [36] Macrophage activation syndrome as the initial manifestation of systemic onset juvenile idiopathic arthritis
    Cuende, E
    Vesga, JC
    Pérez, LB
    Ardanaz, MT
    Guinea, J
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2001, 19 (06) : 764 - 765
  • [37] Systemic juvenile idiopathic arthritis and macrophage activation syndrome: update on pathogenesis and treatment
    Yasin, Shima
    Schulert, Grant S.
    CURRENT OPINION IN RHEUMATOLOGY, 2018, 30 (05) : 514 - 520
  • [38] MACROPHAGE ACTIVATION SYNDROME IN SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS, ONE CENTRE EXPERIENCE
    Hashad, Soad S.
    Etayari, Hala M.
    Almsellati, Iman A.
    Etfil, Majda N.
    Altwati, Aya
    Awhida, Zuhaira
    RHEUMATOLOGY, 2023, 62
  • [39] MACROPHAGE ACTIVATION SYNDROME IN SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS, ONE CENTRE EXPERIENCE
    Hashad, Soad S.
    Etayari, Hala M.
    Almsellati, Iman A.
    Etfil, Majda N.
    Altwati, Aya
    Awhida, Zuhaira
    RHEUMATOLOGY, 2023, 62
  • [40] Treatment for macrophage activation syndrome associated with systemic juvenile idiopathic arthritis in Japan
    Shimizu, Masaki
    Nishimura, Kenichi
    Iwata, Naomi
    Yasumi, Takahiro
    Umebayashi, Hiroaki
    Nakagishi, Yasuo
    Okura, Yuka
    Okamoto, Nami
    Kinjo, Noriko
    Mizuta, Mao
    Yashiro, Masato
    Yasumura, Junko
    Wakiguchi, Hiroyuki
    Kubota, Tomohiro
    Mouri, Mariko
    Kaneko, Utako
    Mori, Masaaki
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2023, 26 (05) : 938 - 945